Synergy between breast-milk and substitutes in a lactating patient with phenylketonuria: Case report

Authors

DOI:

https://doi.org/10.12873/453kong

Keywords:

Infant, phenylketonuria, breastfeeding

Abstract

Introduction: Phenyketonuria (PKU) is an inborn error of metabolism that requires strict dietary control of the amino acid phenylalanine to prevent neurological damage.
Clinical case: Peruvian infant with PKU diagnosed at one month of age. She was started on phenylalanine-free formula (70%) and breastfeeding (30%). Phenylalanine decreased from 9.48 to 1.72 mg/dL. Weight growth was adequate at the end of the follow-up (+0.53 SD), and height was at the lower limit of normal (-1.70 SD).
Discussion: The intervention led to a progressive reduction in phenylalanine levels, reaching safe values (2-6 mg/dL). However, a below-average height was observed, suggesting the importance of balancing the restriction with an adequate intake of natural protein.
Conclusions: The combined use of breast milk and specialized formulas can be a safe and effective strategy for the nutritional management of infants with PKU, provided consistent monitoring and individualized adjustments are made.

References

1. Blau N., van Sproson F.J., Levy H.L. Phenylketonuria. Lancet. 2010;376(9750):1417-1427.

2. Poloni S, Dos Santos BB, Chiesa A, Specola N, Pereyra M, Saborío-Rocafort M, et al. Current Practices and Challenges in the Diagnosis and Management of PKU in Latin America: A Multicenter Survey. Nutrients. 2021 Jul 27;13(8):2566. Doi: 10.3390/nu13082566. PMID: 34444728; PMCID: PMC8399454.

3. Contreras P, Pérez G, Andrade S, Pardo RA. Resultados del Programa Nacional de Pesquisa Neonatal en Chile. Rev Chil Pediatr. 2015;86(2):117–23.

4. Kanufre VC, Starling AL, Reis AB, Lemos MC, Soares DA. Impact of breastfeeding on the metabolic control of phenylketonuria patients. J Pediatr (Rio J). 2010;86(1):65–9.

5. EFSA Panel on Dietetic Products, Nutrition and Allergies. Scientific Opinion on Nutrient Requirements and Dietary Intakes of Infants and Young Children in the European Union. EFSA J. 2013;11(10):3408.

6. Van Spronsen FJ, van Wegberg AMJ, Ahring K, Bélanger-Quintana A, Blau N, Bosch AM, et al. Key European guidelines on phenylketonuria: Diagnosis and treatment. J Inherit Metab Dis. 2017;40(1):10–9.

7. Hassanpour S, Khosravi-Darani K, Ramezan Y, Hashempour- F. Evaluation of producing low phenylalanine milk by formulation procedure for phenylketonuria patients [Internet]. Disponible en: https://nanobioletters.com/wp-content/uploads/2022/12/LIANBS124.142.pdf?utm_source=chatgpt.com

8. Ministerium de Salud. Norma Tecnica de Salud N° 214-MINSA/DGIESP-2024: Atención integral de Salud neonatal. Lima: Ministerium de Salud;2024.

9. Van Rijn M, MacDonald A, Feillet F, Youngs D, Bélanger Quintana A. Breast feeding in infants diagnosed with phenylketonuria (PKU). BMJ Paediatr Open. 2023;7(1):e002066.pmc.ncbi.nlm.nih.gov+15pmc.ncbi.nlm.nih.gov+15pmc.ncbi.nlm.nih.gov+15

10. Bélanger Quintana A, Dokoupil K, Gökmen Özel H, MacDonald A, Rocha JC, van Rijn M, et al. Diet and amino acid supplementation for phenylketonuria patients: 2020 practices in Europe. Mol Genet Metab Rep. 2020;25:100693.

11. European Society for Phenylketonuria and Allied Disorders–Europe (ESPKU). Key European guidelines for the diagnosis and management of phenylketonuria. Lancet Diabetes Endocrinol. 2017;5(9):743–56.

12. Vockley J, Andersson HC, Antshel KM, Braverman NE, Burton BK, Frazier DM, Mitchell JJ, et al. Phenylalanine hydroxylase deficiency: diagnosis and management guideline. Genet Med. 2014 Feb;16(2):188–200. doi:10.1038/gim.2013.157.

13. Weglage J, Wiedermann D, Denecke J, Feldmann R, Koch HG, Ullrich K, Harms E, Möller HE. Individual blood-brain barrier phenylalanine transport determines clinical outcome in phenylketonuria. Ann Neurol. 2001 Oct;50(4):463-7. doi: 10.1002/ana.1226. PMID: 11601498.

14. Zoghi S, Karamizadeh Z, Amirhakimi A, Gharavi M. Comparison of phenylalanine levels and growth parameters in phenylketonuria patients under different feeding regimens. Iran J Pediatr. 2013;23(5):543–8.

15. Pinto A, Gökmen Özel H, Rocha JC, Van Dam E, Ahring K, Bélanger Quintana A, et al. Long term growth in phenylketonuria: a systematic review and meta analysis. Nutrients. 2019;11(9):2070.

Downloads

Published

2025-09-02

How to Cite

[1]
2025. Synergy between breast-milk and substitutes in a lactating patient with phenylketonuria: Case report. Nutrición Clínica y Dietética Hospitalaria. 45, 3 (Sep. 2025). DOI:https://doi.org/10.12873/453kong.

Similar Articles

1-10 of 41

You may also start an advanced similarity search for this article.